Interventions for rosacea (Q24246629)

ORCID Public Data File 2021

26 October 2023

Mark A Graber

M A

Graber

1 reference

26 October 2023

Sally Hollis

Hollis

1 reference

26 October 2023

Maria MMC Chaudhry

Chaudhry

1 reference

26 October 2023

Aditya K Gupta

A K

Gupta

1 reference

26 October 2023

Melissa D Gover

Gover

1 reference

Cochrane Database of Systematic Reviews

26 October 2023

publication date

20 July 2005

0 references

published in

0 references

cites work

Effect of treatment of Helicobacter pylori infection on rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Oxytetracycline in the treatment of ocular rosacea: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Topical metronidazole maintains remissions of rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Comparative effectiveness of tetracycline and ampicillin in rosacea. A controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Treatment of rosacea by metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

A clinical trial of tetracycline in rosacea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Clonidine and facial flushing in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Oral use of azithromycin for the treatment of acne rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Continuous 'microdose' isotretinoin in adult recalcitrant rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Tacrolimus effect on rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Plasma reactive oxygen species activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Subantimicrobial dose doxycycline for acne and rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Rosacea: I. Etiology, pathogenesis, and subtype classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Measuring the severity of rosacea: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Remission of rosacea induced by reduction of gut transit time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Unraveling the mystery of rosacea. Keys to getting the red out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Laser treatment of rosacea: a pathoetiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Incidental control of rosacea by somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Oral tetracyclines for ocular rosacea: an evidence-based review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Acne and rosacea. New and emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

The role of free oxygen radicals in the aetiopathogenesis of rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

Rosacea. Pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

New topical therapy for acne rosacea offers conspicuous improvement, no systemic effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Temperature regulates bacterial protein production: possible role in rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Measurement of the severity of rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Efficacy of doxycycline and tetracycline in ocular rosacea.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

The efficacy of topical metronidazole in the treatment of ocular rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Effect of nadolol on flushing reactions in rosacea.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Topical application of NADH for the treatment of rosacea and contact dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Clarithromycin versus doxycycline in the treatment of rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

1 reference

7 January 2021

Oral spironolactone therapy in male patients with rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Alcohol-induced rosacea flushing blocked by naloxone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Treatment of rosacea with 1% metronidazole cream. A double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

The relapse rate for rosacea after treatment with either oral tetracycline or metrondazole cream

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

1 reference

7 January 2021

Treatment of rosacea: topical clindamycin versus oral tetracycline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

A personal critique on the state of knowledge of Rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

The histopathology of rosacea: 'where's the beef?'

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Rosacea: a clinicopathological approach

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Rosacea: classification and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

Evaluation of topical metronidazole gel in acne rosacea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

New surgical adjuncts in the treatment of rhinophyma: the microdebrider and FloSeal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003262.PUB3

7 January 2021

10.1002/14651858.CD003262.PUB3

Identifiers

DOI

0 references

Fatcat ID

release_iu4u24zh7ze3rh7d4pmiwjuo7y

0 references